Leuprolide Acetate Injection 11.25mg (3-month Depot)- Gelatin-free GnRH agonist.
Composition: Each vial contains 11.25mg of Leuprerolide Acetate.
Indication: Luphere depot showed excellent efficacy, ensuring sustained release of Leuprolide for 3 months:- Central precocious puberty, Prostate cancer, Premenopausal breast cancer, Uterine leiomyomata(Fibroids), Endometriosis
Presentation: Luphere depot Inj 11.25mg powder in vial with an accompanying vial of solvent.
Storage Condition: Store below 30°C, protected from light.